• Super-Enhancer Hijacking of LINC01977 Fuels Early LUAD Progr

  2026-06-09

  Zhang et al. uncovered how super-enhancer hijacking drives LINC01977 overexpression, fueling malignancy in early-stage lung adenocarcinoma by activating the canonical TGF-β/SMAD3 pathway. These findings clarify an epigenetic mechanism underlying tumor progression and offer a potential therapeutic target for intervention.

• Leveraging Dextromethorphan Hydrobromide for Translational N

  2026-06-09

  This article examines the mechanistic foundation and translational potential of Dextromethorphan hydrobromide as a research-grade NMDA receptor antagonist. Integrating insights from metabolic disease research and recent advances in neuroprotection, we offer strategic guidance for researchers navigating the intersection of excitotoxicity inhibition, cerebral ischemia modeling, and cross-domain therapeutic innovation.

• Tetraethylammonium Chloride: Precision in K+ Channel Blockad

  2026-06-08

  Tetraethylammonium chloride (TEAC) stands out for its dual-site K+ channel inhibition, enabling nuanced interrogation of ion conduction in vascular and metabolic research. This article details robust experimental workflows, troubleshooting tactics, and translational insights, with a practical bridge from reference studies to optimized laboratory protocols.

• Practical Guide to 740 Y-P: PI 3-Kinase Activator in Cell Re

  2026-06-08

  740 Y-P is a potent, cell-permeable PI 3-kinase activator designed for precise modulation of the PI3K/AKT pathway in cell-based and biochemical assays. It is best suited for vesicular trafficking research, neuronal cell survival experiments, and cancer signaling studies where direct control of PI3K activation is required. Use is not recommended in workflows that require ethanol solubility or extended solution storage.

• Lamotrigine in Translational Research: New Mechanistic Horiz

  2026-06-07

  This thought-leadership article delivers an advanced, evidence-driven perspective on Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine), highlighting its dual sodium channel blocking and serotonin pathway inhibition. Bridging mechanistic insight with practical protocols, it interprets emerging blood-brain barrier (BBB) models and provides actionable guidance for translational researchers targeting neurological and cardiac disorders. Drawing on recent literature and competitive analyses, it positions APExBIO’s high-purity Lamotrigine as a cornerstone for reproducible, future-facing CNS and cardiac research.

• Radioiodinated Balsalazide for Selective Imaging of Ulcerati

  2026-06-06

  This study introduces a highly selective radiotracer, [125/131I]balsalazide, for imaging ulcerative colitis (UC) in mouse models. The research establishes a robust radioiodination protocol and demonstrates the tracer's high in vivo colon specificity, addressing prior limitations in radiotracer stability and biodistribution monitoring over 24 hours.

• Immobilized Microalgae Extracts Enhance Antioxidant Packagin

  2026-06-05

  This study demonstrates that immobilizing Chlorella sp. in a silk fibroin–reinforced sodium alginate matrix nearly doubles antioxidant yield and biomass compared to suspension cultures. The resulting extracts, when incorporated into biodegradable films, significantly improve oxidative stability and food preservation, offering a sustainable approach to active packaging.

• YM 58483 (BTP2): Applied SOCE Inhibition in Fibrosis Models

  2026-06-05

  YM 58483 (BTP2) delivers highly selective SOCE inhibition, empowering immunology and fibrosis researchers to dissect calcium-dependent pathways with precision. Its proven effectiveness in modulating the ORAI2/JNK/NFAT1/TGF-β1 axis makes it a pivotal tool for modeling postirradiation tissue fibrosis and T cell-driven responses.

• Sinapine Disrupts Gαq-PLCβ3 Axis to Alleviate Cardiovascular

  2026-06-04

  This study identifies sinapine as a selective inhibitor that disrupts the Gαq-PLCβ3 interaction by targeting PLCβ3 EF hand domains, thereby ameliorating aldosteronism and hypertension in preclinical models. The work introduces a novel strategy for modulating the renin-angiotensin-aldosterone system (RAAS) with improved specificity and fewer side effects compared to conventional Gαq or pan-PLC inhibitors.

• BAPTA-AM: Cell-Permeable Calcium Chelator for Precision Assa

  2026-06-04

  BAPTA-AM stands out as a gold-standard tool for manipulating intracellular calcium dynamics in live-cell studies. Its cell-permeable design enables targeted regulation of calcium signaling, unlocking advanced apoptosis assays and high-fidelity neuroprotection models.

• Efficacy and Safety of Azilsartan Medoxomil in Hypertension:

  2026-06-03

  This systematic review and meta-analysis rigorously evaluates azilsartan medoxomil’s efficacy and safety for hypertension, including patients with diabetes. The findings position TAK 491 as one of the most effective angiotensin II receptor blockers for blood pressure reduction, with no increased risk of adverse events compared to controls.

• CBD Modulates Orofacial Inflammatory Pain via Multi-Domain M

  2026-06-03

  This study demonstrates that cannabidiol (CBD) effectively attenuates both the sensory and emotional components of orofacial inflammatory pain in murine models. By dissecting the peripheral and central pathways—including CB1 and CB2 receptor signaling—the research highlights CBD's translational potential for comprehensive pain management and supports the need for targeted molecular tools in pain mechanism studies.

• Verapamil HCl: L-Type Calcium Channel Blocker in Bone & Canc

  2026-06-02

  Verapamil HCl is a well-characterized L-type calcium channel blocker with robust solubility and validated efficacy in inhibiting calcium influx, thereby modulating cellular excitability and apoptosis. Its bench-to-model translational value spans from myeloma cell research to attenuation of arthritis inflammation and suppression of osteoporosis-related bone turnover, as supported by recent peer-reviewed studies.

• Otilonium Bromide: Antimuscarinic Agent for Cholinergic Rese

  2026-06-02

  Otilonium Bromide is a high-purity antimuscarinic agent used to inhibit acetylcholine receptors in neuroscience and smooth muscle research. Its robust solubility and validated specificity enable precise modulation of the cholinergic signaling pathway. This article details its biological rationale, documented mechanisms, application limits, and protocol integration.

• E-4031 and the Next Era of 3D Cardiac Electrophysiology

  2026-06-01

  Explore how E-4031, a gold-standard hERG potassium channel blocker, is redefining translational strategies in 3D cardiac electrophysiology research. This article unpacks mechanistic insights, protocol guidance, and the transformative impact of high-resolution 3D mapping platforms—empowering researchers to model arrhythmogenic risk with unprecedented fidelity.

3720 records 18/248 page Previous Next First page 上5页 1617181920 下5页 Last page